Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Motion-Robust Quantitative DCE-MRI For The Assessment Of Gynecologic Cancer
NCT04893434Phase 1Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2021
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Changes in Ktrans value at 48 hours. Started May 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04893434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893434.